CLS Holdings USA, Inc. (CLSH)
CLS Holdings USA, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Las Vegas, FL, US. The stock last traded at $0.04, up 0.00% on the session, giving a market capitalisation of $5.9M. On trailing twelve-month figures it carries a trailing P/E of -0.79, a net margin of -22.5%. Its beta of 1.18 implies it has historically moved more than the broad market.
CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.
CLS Holdings USA, Inc. is most often compared with the following Healthcare names: